Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
This study is currently recruiting participants.
Verified June 2012
by University of Medicine and Dentistry New Jersey
Study NCT01407562 Information provided by University of Medicine and Dentistry New Jersey
First Received on July 20, 2011. Last Updated on June 12, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer - Female
Additional conditions recognized in this trial
Breast Neoplasms
Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
Pazopanib
Paclitaxel
Carboplatin
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
University of Medicine and Dentistry New Jersey
National Cancer Institute (NCI)
GlaxoSmithKline
Back to top of Main Content